|
14 Feb 2025
|
Quarterly Results |
- |
|
14 Nov 2024
|
Quarterly Results |
- |
|
13 Aug 2024
|
Quarterly Results |
- |
|
25 May 2024
|
Audited Results |
- |
|
10 May 2024
|
Others |
(Revised) |
|
14 Feb 2024
|
Quarterly Results |
- |
|
08 Nov 2023
|
Quarterly Results |
- |
|
14 Aug 2023
|
Quarterly Results |
- |
|
29 May 2023
|
Audited Results & Final Dividend |
- |
|
14 Feb 2023
|
Quarterly Results |
- |
|
14 Nov 2022
|
Quarterly Results |
- |
|
10 Oct 2022
|
Others |
Inter alia, consider and approve the allotment of Equity Shares of the Company by way of preferential issue to promoters / non promoters. |
|
13 Aug 2022
|
Quarterly Results |
- |
|
28 May 2022
|
Audited Results |
- |
|
14 Feb 2022
|
Quarterly Results |
- |
|
12 Nov 2021
|
Quarterly Results |
- |
|
14 Aug 2021
|
Quarterly Results |
- |
|
29 Jun 2021
|
Audited Results |
- |
|
12 Feb 2021
|
Quarterly Results |
- |
|
14 Nov 2020
|
Quarterly Results |
- |
|
15 Sep 2020
|
Quarterly Results |
- |
|
04 Aug 2020
|
Others |
- |
|
30 Jun 2020
|
Audited Results |
- |
|
13 Feb 2020
|
Quarterly Results |
- |
|
14 Nov 2019
|
Quarterly Results |
- |
|
12 Aug 2019
|
Quarterly Results |
- |
|
29 May 2019
|
Audited Results |
- |
|
25 Feb 2019
|
Others |
To consider: 1. Acquire the Equity Shares of M/s Azillian Healthcare Private Limited, subject to the approval of members; 2. Acquire assets from M/s Oxford Pharma (related party). |
|
16 Jan 2019
|
Quarterly Results & Others |
Increase in Authorised Capital. |
|
14 Nov 2018
|
Quarterly Results |
- |
|
14 Aug 2018
|
Unaudited Financial Results |
- |
|
25 May 2018
|
Audited Results |
- |
|
14 Feb 2018
|
Quarterly Results |
- |
|
14 Nov 2017
|
Quarterly Results |
- |
|
11 Aug 2017
|
Quarterly Results |
- |
|
29 May 2017
|
Audited Results |
- |
|
13 Feb 2017
|
Quarterly Results |
- |
|
12 Nov 2016
|
Quarterly Results |
- |
|
12 Aug 2016
|
Quarterly Results |
- |